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Abstract
Background and aims
The shortage of organs for transplantation has led to increased use of organs procured from
donors after cardiac death (DCD). The effects of cardiac death on the liver remain poorly
understood, however. Using livers obtained from DCD versus donors after brain death
(DBD), we aimed to understand how ischemia/reperfusion (I/R) injury alters expression of
pro-inflammatory markers ceramides and influences graft leukocyte infiltration.
Methods
Hepatocyte inflammation, as assessed by ceramide expression, was evaluated in DCD (n =
13) and DBD (n = 10) livers. Allograft expression of inflammatory and cell death markers,
and allograft leukocyte infiltration were evaluated from a contemporaneous independent
cohort of DCD (n = 22) and DBD (n = 13) livers.
Results
When examining the differences between transplant stages in each group, C18, C20, C24
ceramides showed significant difference in DBD (p<0.05) and C22 ceramide (p<0.05) were
more pronounced for DCD. C18 ceramide is correlated to bilirubin, INR, and creatinine after
transplant in DCD. Prior to transplantation, DCD livers have reduced leukocyte infiltration
compared to DBD allografts. Following reperfusion, the neutrophil infiltration and platelet
deposition was less prevalent in DCD grafts while cell death and recipients levels of serum
aspartate aminotransferase (AST) of DCD allografts had significantly increased.
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Conclusion
These data suggest that I/R injury generate necrosis in the absence of a strong inflamma-
tory response in DCD livers with an appreciable effect on early graft function. The long-term
consequences of increased inflammation in DBD and increased cell death in DCD allografts
are unknown and warrant further investigation.
Introduction
The increasing demands for suitable organ donors for liver transplantation exceed the number
of donors which has remained largely static [1]. The worsening organ shortage is reflected in
the median time to transplant in wait-listed adult patients. In the United States median time
increased from 14.8 months in 2004 to 19.5 months in 2011. As such, transplant centres and
allocation organizations have attempted to expand the pool of acceptable donors, including the
use of DCD donors [2]. Although some centres have reported good results by using DCD allo-
grafts, other data indicates that recipients of controlled DCD liver allografts have an increased
incidence of graft dysfunction, early graft loss and cholangiopathy as compared to recipients of
DBD livers [3–7].
The pathophysiology of cardiac death is markedly different from that of brain death. As
compared to livers obtained from DBD, in which there is no consistent proceeding cardiac
arrest, DCD livers are subjected to additional hypoxic insult. However, brain death generates
an inflammatory response with the release of various pro-inflammatory mediators, leading to
upregulated expression of adhesion molecules on vascular endothelium and subsequent leuko-
cyte tissue infiltration [8–10]. In a previous study, we demonstrated that prior to transplanta-
tion DCD allografts have lower expression of ICAM-1, potentially suggesting less allograft
inflammation [11].
Ischemia/reperfusion (I/R) injury is associated with the release of reactive oxygen species
and pro-inflammatory mediators [12], and there is evidence to suggest that brain death fol-
lowed by I/R injury synergistically aggravates the insult associated with cold storage [10, 13].
Elevated levels of ceramides, sphingolipid molecules associated with I/R injury, promote
inflammation and downstream apoptosis by enhancing susceptibility to palmitate-induced cell
death [14–16]. The role of ceramides has yet to be described in human liver transplantation
[15] despite previous observations of ischemia/reperfusion-induced accumulation of ceramides
in various organs, including the liver [14, 16].
In this study we assessed the impact of I/R on DCD as compared to DBD liver allografts by
assessing leukocyte infiltration, expression of pro-inflammatory molecules, including cer-
amides, and cell death before and after reperfusion (study design as seen in Fig 1).
Patients and Methods
Patient sampling
Demographic and clinical data of donors and recipients were drawn from donor offer data and
hospital records. Cohort 1 with DCD (n = 13) and DBD (n = 10) biopsies were applied to assess
ceramide expression. Cohort 2 with DCD (n = 22) and DBD (n = 13) allografts were evaluated
for immunohistochemistry assessment.
Tru-cut biopsies were taken prior to and approximately 1 hour ± 15min following reperfu-
sion. All biopsies were immediately snap-frozen in liquid nitrogen and transferred to –80°C
until the time of processing. Details about the sample collection were provided in supporting
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information (S1 File). Donor clinical data (Table 1) and recipient clinical data (Table 2)
include both cohorts. The study was approved by the Ethics Committee of King’s College Hos-
pital. All retrievals and transplant were performed by King’s College Hospital transplant team,
and only adults transplant (age>18) were considered for this study. Consent was obtained
from all patients/their next of kin for collection of data and they were given the option to with-
draw written consent freely, and all clinical investigation has been conducted according to the
principles expressed in the Declaration of Helsinki. None of the transplant donors were form a
vulnerable population and all donors or next of kin provided written informed consent that
was freely given. Patient information was anonymized prior to use in this study.
Ceramide analysis
Liquid chromatography-mass spectrometry (LC-MS) analysis was performed using a previ-
ously published method [17]. The identification of ceramides Cer16, Cer18, Cer20, Cer22 and
Cer24 (with the number suffix denoting the length of the acyl chain) was achieved by structure
and fragmentation patterns comparison of the MS2 data with a C8 ceramide standard and liter-
ature [18–21]. Five ceramides were measured in the LC-MS data using Waters Mass Lynx soft-
ware (Waters Corporation, Milford, MA) and their peak area ratios to internal standard were
calculated. Mean ratio values were used to plot the heat-map using an open source ‘R’ package,
'gplots' [22]. Subsequently univariate non-parametric MannWhitney test was performed to
examine the mean difference of each ceramide level in each group at pre- and post-transplanta-
tion stage, as well as between DBD and DCD at both stages.
APAAP staining
Approximately 7μm cryostat sections were air-dried and fixed with acetone for 10 minutes at
room temperature and stained using an alkaline phosphatase anti-alkaline phosphatase
(APAAP) staining technique. Sections were incubated with monoclonal antibodies neutrophil
elastase (NP57, neutrophils), ICAM-1 (6.5B5), Von Willebrand Factor (F8/86) and VCAM-1
Fig 1. Study design. Two independent cohorts of immunohistochemistry and targeted lipids analysis found
that DBD and DCD liver allografts have different pathways for I/R injury.
doi:10.1371/journal.pone.0148815.g001
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(1.4C3) CD3 (UCHT-1, T lymphocytes) (DAKO Ltd, HighWycombe, UK), HLA class II
(NFK1, monomorphic HLA-DR, DP)[23] and P-selectin (AK4), CD41 (MWReg30, anti-plate-
lets) and FasL (G247-4) (Pharmingen, Ltd, San Diego, USA). More details about staining pro-
cedures are provided in S1 File.
TUNEL staining
TUNEL technique was performed to detect apoptosis in situ using R&D systems kit. Frozen
liver tissue sections were deparaffinised and rehydrated through three changes between xylene
and graded alcohol, then washed in PBS for 5 min, and incubated in 20 lg/mL proteinase K for
15 min at room temperature. The DNA fragmentation detection Kit Colorimetric-TdT
Enzyme was used according to the manufacturer’s instructions. TUNEL staining was assessed
by cell counting of positive cells. 2 sections from each biopsy were stained and counted and
between10-20 fields were assessed. Only positively stained hepatocytes were considered and
the mean of cell counting was calculated.
Table 1. Summary of clinical data for liver donors.
Cohort 1 DBD DCD p-value[b]
(N = 10) (N = 13) DBD vs DCD
Age(years) 51(19) 54(13) 0.69
Gender(female/male) 7/3 7/6 0.67
No 5 9
Hepatic steatosis Mild (<30%) 2 4 0.13
Moderate (30–60%) 3 0
GGT (IU/L) [a] 35(14) 28(19) 0.73
AST (IU/L) [a] 39(6) 70(53) 1
Bilirubin (μmol/L) [a] 14(13) 8(4) 0.79
ITU stay (days) 5(9) 2(2) 0.48
Inotrop support (Y/N) 7/3 9/4 1
WIT (min) NA 20(7)
CIT (min) 496(212) 389(117) 0.60
Cohort 2 DBD DCD p-value[b]
(N = 13) (N = 22) DBD vs DCD
Age(years) 33(17) 39(15) ns
Gender(female/male) 7(6) 10(12) ns
ITU stay (hours) 53(47) 72(51) ns
Inotrop support (Y/N) 11/2 15/7 0.43
No 8 12
Hepatic steatosis Mild (<30%) 5 8 0.74
Moderate (30–60%) 0 2
WIT (min) NA 14(5)
CIT (min) 671(177) 477(112) 0.02
AST (IU/L) [a] 87(10) 65(9) ns
DBD, donation after brain death; DCD, donation after circulatory death; GGT, gamma-glutamyl transferase; AST, aspartate aminotransferase; ITU,
intensive therapy unit; WIT, warm ischemia time; CIT, cold ischemia time.
Continuous values are expressed as means (standard deviation).
[a] Tested on the day of operation
[b] Mann Whitney test or Fisher exact test.
ns: not significant; NA, not applicable.
doi:10.1371/journal.pone.0148815.t001
The Impact of Ischemia/Reperfusion Injury on Two Deceased Donor Types
PLOS ONE | DOI:10.1371/journal.pone.0148815 February 10, 2016 4 / 14
Assessment of staining
The percentage area of CD3, CD41, neutrophil elastase, P-selectin and FasL expressions were
quantitated by morphometric point counting as previously described [11]. Details of assess-
ment methods were included in the S1 File.
Statistical analysis
The results of the immunohistochemistry findings were analysed with respect to donor, Inten-
sive Care Unit (ICU) parameters using Chi-square, Student’s t-test and MannWhitney U for
proportions and means, and Spearman’s test to determine significant correlations.
For ceramide analysis, spearman’s correlation analysis was applied separately in DCD and
DBD groups to investigate the correlation of ceramides at both pre & post-transplant with
recipients’ 14-day clinical data. All obtained p values were adjusted for multiple comparisons
using Benjamini and Hochberg correction to control the false discovery rate (FDR) [24].
Table 2. Summary of clinical data for liver recipients.
Cohort 1 DBD DCD p-value[b]
(N = 10) (N = 13) DBD vs DCD
Age (years) 42(13) 57(6) 0.56
Gender (female/male) 7/3 4/9 0.10
BMI (kg/m2) 24(4) 26(5) 0.34
MELD Score (median) 12 13 1.0
Alcoholic liver disease (ALD) 2 9
Primary sclerosing cholangitis (PSC) 2 0
Hepatic C virus (HCV) 1 5
Hepatocellular carcinoma (HCC) 0 2 0.07
Biliary atresia (BA) 0 0
Others 5 1
AST (IU/L) [a] 963(611) 2356(2714) 0.17
Bilirubin day 5 (μmol/L) 80(74) 74(70) 0.92
INR day 2 1.43(0.16) 1.51(0.46) 0.65
One year audit report (survival rate) 100% 81.8% NA
Cohort 2 DBD DCD p-value[b]
(N = 13) (N = 13) DBD vs DCD
Age (years) 44(17) 43(15) ns
Gender (female/male) 9/4 7/6 ns
Alcoholic liver disease (ALD) 2 1
Primary biliary cirrhosis (PBC) 2 2
Hepatic C virus (HCV) 2 4
Cryptogenic 4 1 0.73
Autoimmune hepatitis 2 3
Hepatic B virus (HBV) 1 2
DBD, donation after brain death; DCD, donation after circulatory death; BMI, body mass index; MELD, model for end-stage liver disease; ALD, alcoholic
liver disease; PSC, primary sclerosing cholangitis; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; BA, biliary atresia; AST, aspartate
aminotransferase; INR, international normalized ratio.
Continuous values are expressed as means (standard deviation).
[a] Maximum value during 14-day period
[b] Mann Whitney test or Fisher exact test.ns: not significant; NA, not applicable.
doi:10.1371/journal.pone.0148815.t002
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OPLS-DA (SIMCA 13.0.2, Umetrics, Sweden) was used for multivariate analysis using the 5
ceramides as variables. Two models were investigated, DBD vs. DCD (n = 46), and DBD vs.
DCD for liver biopsies from non-steatosis (n = 28). Statistical calculations were conducted in
SPSS 22 (IBM: Armonk, United States).
Results
Clinical outcomes
There were no significant differences in donor and recipients clinical parameters between the
two groups (Tables 1 & 2) or post-transplant biochemical outcome.
Multivariate analysis (OPLS-DA) for ceramides at per transplant stage
OPLS-DA model (Fig 2) between pre and post-transplant grafts was built according to the
selected 5 ceramides (Table A in S1 File), Cer (34:1), Cer (36:1), Cer (38:1), Cer (40:1) and Cer
(42:1).
The score plot (Fig 2A) showed separation of these two transplant stages, the model’s fig-
ures of merit were R2X = 0.89. R2X explains a data percentage (89%) which is explained by this
model. The S-plot in Fig 2B indicated that Cer24 correlated with pre transplant stage and the
other four ceramides correlated with post transplantation. Cer18 and Cer24 showed the highest
correlation (p(corr) = 0.8) with post and pre transplantation stage, respectively.
Similarly, the OPLS-DA model for non-fatty biopsies in Fig 2C addressed figures of merit
with R2X = 0.88, while Cer18 correlated most with post-transplant in the S-plot (p(corr) = 0.7)
and Cer24 correlated with pre-transplant (p(corr) = 0.8) (Fig 2D).
Univariate analysis for ceramides per donor type during transplant
The amounts for the 5 selected ceramides were measured and plotted in a heat-map dendro-
gram (Fig 3). When comparing DBD-pre to DCD-pre, no significant difference was observed
for all five ceramides, and the same result applies to DBD-post and DCD-post.
To assess the impact of ischemia injury, all 46 biopsies and their ceramides levels were com-
pared between pre- and post-transplantation within each donor group. Four ceramides were
Fig 2. Multivariate analysis of pre vs. post biopsies and ceramides distribution. (A) OPLS-DA score plot
visualizing the grouping of pre vs. post for all biopsies. (B) S-plot illustrating ceramides correlation to groups
for model in A. (C) OPLS-DA score plot showing group separation between pre- and post-transplant for none
steatotic grafts. (D) S-plot indicating ceramides correlation to groups for model in C.
doi:10.1371/journal.pone.0148815.g002
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found altered in DBD at post-transplantation (higher Cer18, Cer20, Cer22 and lower Cer24)
(p<0.05) while one ceramide, Cer24, decreased in DCD post-transplantation (p<0.05).
Correlation of ceramides to clinical data
Spearman’s rank correlation analysis was applied separately in DCD and DBD groups to inves-
tigate the correlation of ceramides at both pre & post-transplant with recipients’ 14-day clinical
data. According to the correlation result, creatinine, INR, bilirubin, donor age andWIT show
high significance, then Benjamini and Hochberg false discovery correction was used to test the
p value of those 5 parameters. After the p-value correction, Cer18 showed significant correla-
tion to bilirubin and INR at pre-transplantation, creatinine at post-transplantation in DCD,
while no significant correlation reflect in DBD group at both pre and post-transplantation (see
details in Table B in S1 File).
Graft leukocyte infiltration, activation marker expression and cell death
prior to transplantation
DCD allografts had significantly lower levels of neutrophil and T cell infiltration compared to
DBD livers (1.6 ± 0.5 vs. 2.3 ± 1.1; p = 0.03 and 0.7 ± 0.6 vs.1.5 ± 0.7; p = 0.02 respectively) (Fig
4A). The tumour necrosis factor (TNF)-family member activation marker Fas ligand (FasL)
was expressed at a much lower level in DCD as compared to DBD allografts (1.7 ± 1 vs. 5.8 ± 4;
p<0.001) (Fig 4A).
There were similar number of allografts expressing intermediate levels of ICAM-1 (54% of
DCD and 53% of DBD expressing grade 2) (Fig 4B). However, only 27% of DCD livers (6/22)
as compared to 47% of DBD livers (6/13) expressed high levels of ICAM-1 (grade 3). While
none of the DBD allografts expressed low levels of ICAM-1 (grade 1), 18% of DCD allografts
(4/22) demonstrated low levels of ICAM-1 (grade 1). P-selectin, which is expressed on acti-
vated platelets, was expressed at significantly lower levels in DCD as compared to DBD allo-
grafts prior to transplantation (0.24 ± 0.3 vs. 0.57 ± 0.5; p = 0.04) (0.81 ± 0.7 vs. 2.7 ± 1; p<
0.001). The platelet marker CD41 also was expressed at lower levels in DCD compared to DBD
allografts (0.81 ± 0.7 vs. 2.7 ± 1; p< 0.001), and platelets appeared to be primarily deposited on
the sinusoidal endothelium. Finally, expression of VonWillebrand factor (vWF), a pro-
Fig 3. Heat-map showing distinct ceramides profiles of DBD and DCD tissue in 46 transplant samples.
Values are mean amounts per donor group at pre and post-transplantation stages. A clustering analysis
(dendrogram) shows which lipids differ most; red depicts increased amounts and green decreased.
doi:10.1371/journal.pone.0148815.g003
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coagulant factor released by activated endothelium, was lower in DCD compared to DBD liv-
ers. Of 13 DCD livers 11 (85%) expressed grade 0 and 2 allografts (15%) grade 1 of vWF stain-
ing. In contrast 5 out 12 DBD livers (42%) expressed vWF at grade 0 (p = 0.02), 6 (50%) at
grade 1 and 1 (8%) as grade 2 (p = 0.04). Terminal deoxynucleotidyl transferase dUTP nick
end labelling (TUNEL) staining, which detects apoptotic cells, demonstrated low levels of cell
death in the pre-transplantation biopsies in both DCD and DBD livers with no significant dif-
ferences between the two groups (1.1 ± 1.4 vs. 1.8 ± 2.8 cell per field; p = 0.7) (Fig 5A and 5C).
Graft function, leukocyte infiltration, activation marker expression and
cell death following reperfusion
Recipients of DCD allografts had significantly higher AST levels in the first three days follow-
ing transplantation compared to the DBD group (Fig 6A).
Comparison of the expression of neutrophil elastase, CD41, P-selectin and vWF from DCD
and DBD pre- and post-reperfusion liver biopsies were made to determine if any measurable
differences existed. None of the DCD livers demonstrated increased in neutrophil infiltration
in post- versus pre-reperfusion biopsies (p = 0.01). In contrast, approximately 54% of DBD
allografts had significantly increased neutrophil infiltration post- reperfusion as compared to
pre-reperfusion DBD allografts (Fig 6B). Neutrophil infiltration was observed predominantly
in sinusoids and portal tracts. Only 8% (1/13) of DCD livers had increased platelet deposition
post-reperfusion while 31% (4/13) of DBD livers had increased platelet deposition, but this dif-
ference was not statistically significant (p = 0.3). The pattern of vWF was largely reversed, with
Fig 4. Immunohistochemistry results prior to transplantation. (A) Leukocyte infiltration and FasL
expression in liver allografts prior to transplantation. Biopsies from DBD and DCD liver biopsies were stained
with monoclonal antibodies against neutrophil elastase, CD3 and FasL. (B) Expression of ICAM-1 in liver
allografts prior to transplantation.
doi:10.1371/journal.pone.0148815.g004
Fig 5. Representative TUNEL staining in pre- and post-reperfusion biopsies in DBD and DCD livers.
(A) pre-reperfusion biopsies in DBD, (B) post-reperfusion biopsies in DBD, (C) pre-reperfusion biopsies in
DCD, (D) post-reperfusion biopsies in DCD.
doi:10.1371/journal.pone.0148815.g005
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85% (11/13) of DCD livers demonstrating an increase in expression compared to 31% (4/13) of
DBD grafts (p = 0.01). The expression of vWF was predominately located on sinusoidal endo-
thelium. There were no significant differences in expression of adhesion molecules. However,
direct comparison of DCD and DBD allografts following reperfusion revealed significantly
higher levels of cell death in the DCD allografts versus their DBD counterparts (30 ± 19 vs.
4.4 ± 4 cells per field; p = 0.001). Histological analysis demonstrated that cell death occurred
predominantly in hepatocytes and sinusoidal endothelium (Fig 5) and that there was a correla-
tion between duration of WIT and cell death in DCD livers (Fig 6C).
Correlation of pro-inflammatory molecules with donor clinical parameters
In DCD livers high levels of neutrophil infiltration and CD41 deposition were correlated with
traumatic head injury in the donor (R: 0.570, p = 0.04 and R: 0.632, p = 0.02 respectively). High
levels of CD41 deposition were correlated with extended CIT (R: 0.729, p = 0.005). Increased
levels of neutrophil infiltration and expression of ICAM-1, vWF and CD41 were associated
with extended ICU stay of the DCD donors (R: 0.783, p = 0.002; R: 0.818, p = 0.001; R: 0.703,
p = 0.01; R: 0.708, p = 0.007 respectively). Finally, prolongedWIT correlated with increased lev-
els of cell death following transplantation (R: 0.712, p = 0.01). There was no other significant
association between post-reperfusion inflammatory events and transplant outcome.
Discussion
The increasing demand for liver allografts combined with largely static organ donation rates
lead to the broadening of donor inclusion criteria. One area of intense interest is the use of
DCD allografts, which have a prolonged period of WIT [25]. Data indicate that patients receiv-
ing DCD allograft are at higher risk of biliary complications, graft failure and patient mortality
[4], and although outcomes can be improved with careful donor selection, they are not as
favourable as with DBD allografts [3, 6, 7]. To better understand the molecular mechanisms of
worsened DCD graft function we compared the expression of various inflammatory mediators
at pre-and post-perfusion in DCD and DBD allografts.
Ceramides are well known markers of inflammation and elevated ceramide level are thought
to produce inflammation and downstream apoptosis by enhancing susceptibility to palmitate-
induced cell death [15]. During I/R injury, accumulation of ceramides was observed in tissues,
however it is not yet known how the size of a ceramide determines inflammation response [14,
Fig 6. Immunohistochemistry results following reperfusion. (A) Recipient serum levels of aspartate
aminotransferase (AST) following transplantation. (B) Neutrophil infiltration, platelet activation and
expression of vWF post-reperfusion. (C) Correlation between post-reperfusion cell death andWIT.
doi:10.1371/journal.pone.0148815.g006
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16]. In-vitro experiments showed that high level of C16-ceramide resulted in TNF-α-induced
hepatocyte apoptosis [26]. Conversely elevated de-novo C18-ceramide, synthesised by CerS4
in the liver, was also found to function as a powerful pro-apoptotic activator in tumour cells
[27, 28]. Bigger ceramides also called very long chain ceramides (C24-ceramides) are thought
to be the most abundant in healthy liver and their decrease can in turn indicate liver pathology
[29].
In this study five ceramides of increasing acyl chain from long to very long chain: C16, C18,
C20, C22 and C24 were measured. These results are in line with what was expected from IR
response, increased long chain (C18-C20) and decreased very long chain (C24) suggesting
higher inflammation at post-transplant stage. C22 increased its level after graft implantation;
this is not in agreement with an inflammation response considering it is also a very long chain
ceramide. Differences between DBD and DCD were insignificant, however overall changes in
DBD from pre- to post transplantation for C18, C20, C24 (p<0.05) were significant and C22
(p<0.05) were more pronounced for DCD suggesting that the inflammation response was
more severe in DBD.
Lang et al. found that bilirubin induces ceramide formation [30], which explains the high
correlation of bilirubin and Cer18 at DCD pre-transplant stage in our study. Moreover, as bili-
rubin is an antioxidant that can stimulate apoptosis of various cells [31, 32], the higher Cer18
level in DCD at pre-transplant stage compared with DBD indicates that severe apoptosis took
place in DCD hepatocytes. INR, the assessment parameter for coagulation monitoring [33],
indicated the liver injury when its value is elevated, hence, the correlation of INR with Cer18 in
DCD post-transplant demonstrates ischemia/reperfusion injury in DCD. The association
between C18-ceramide and serum level of creatinine is of interest as renal dysfunction post-
transplant has been seen to occur at higher rate in liver transplantation from DCD [34].
Significantly higher levels of neutrophil, T cell infiltration, and ICAM-1 expression were
detected in DBD compared to DCD liver allografts prior to transplantation. This pattern fits
with data from animal and human studies that demonstrates that brain death (BD) results in a
systemic inflammatory response in the donor with the release of various cytokines and chemo-
kines [9, 35]. Production of these pro-inflammatory molecules leads to increased expression of
adhesion molecules on the endothelium and subsequent leukocyte infiltration and damage to
parenchymal cells.
Increased neutrophil migration and platelet activation in DBD livers correlates with donor
cerebral ischemia as reported in both renal and liver transplantation, and the level of hepatic
inflammation is also associated with traumatic brain injury [11, 36]. Our results demonstrated
increased platelet adhesion and vWF expression prior to reperfusion in DBD livers, and the
extent of platelet adhesion correlated with prolonged CIT. Platelet adhesion to hepatic sinusoi-
dal endothelium induces release of P-selectin and vWF and prior to transplantation has been
correlated to CIT duration and graft function in both animal models and human liver trans-
plantation [37–39]. As extended cold preservation damages endothelial cells, these results may
also reflect the shorter cold storage times for DCD allografts [40].
In an animal model, the inflammation associated with brain death plays a synergistic role
with extended CIT leading to a more vigorous I/R injury [13]. Increased neutrophil infiltration
in DBD livers likely reflects more effective transmigration due to elevated ICAM-1 expression
pre-reperfusion. However, although DBD allografts had increased neutrophil infiltration and
platelet deposition post-reperfusion, there was relatively consistent expression of adhesion
molecules between DBD and DCD allografts. Interestingly, DCD livers upregulate vWF post-
reperfusion more substantially compared to DBD livers. The etiology of this upregulation is
unclear but is potentially related to the warm ischemic process unique to DCD allografts. Lim-
ited animal work demonstrated that warm ischemia associated with I/R injury in the gut
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induces upregulation of vWF expression [41]. The consequences of the increased endothelial
vWF expression, for platelet binding or otherwise, were not immediately evident.
We also demonstrated a significantly higher level of cell death in DCD livers following
reperfusion, which correlated to the duration of WIT. Hepatocyte apoptosis and liver necrosis
are common features of I/R injury in the liver [42]. Duration of WIT significantly contributes
to the extent of cell death in animal models and human liver transplantation [43, 44]. Warm
ischemia primes the cellular intrinsic pathway of apoptosis by reducing hepatocyte antioxidant
capabilities, priming mitochondria to produce reactive oxygen species upon reperfusion and
contributing to the development of mitochondrial permeability. This subsequently leads to the
release of pro-apoptotic and -necrotic factors, the former activated by the caspase cascade in
programmed cell death [12, 45]. Conversely, upregulated FasL, an important regulator of the
extrinsic apoptotic pathway, potentially accounts for the cell death observed in DBD livers,
which has been previously described [46]. Ceramides, which activate the NLRP3 inflamma-
some, were also more elevated in DBD allografts, again potentially indicating Fas-FasL medi-
ated apoptosis.
In conclusion, as compared to DBD allografts, DCD grafts appear to have reduced leukocyte
infiltration before and after transplantation. Ceramides can be used as indicator of inflamma-
tion for liver transplantation. However, DCD livers have a higher rate of cell death that corre-
lates with WIT and post-transplant serum AST levels, suggesting that DCD livers are prone to
necrosis rather than inflammation.
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